Where Will Sio Gene Therapies Inc (SIOX) Stock Go Next After It Is Up 25.00% in a Week?

Thursday, December 15, 2022 12:50 PM | InvestorsObserver Analysts

Mentioned in this article

Where Will Sio Gene Therapies Inc (SIOX) Stock Go Next After It Is Up 25.00% in a Week?

Overall market sentiment has been high on Sio Gene Therapies Inc (SIOX) stock lately. SIOX receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

Sio Gene Therapies Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on SIOX!

See Full SIOX Report

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With SIOX Stock Today?

Sio Gene Therapies Inc (SIOX) stock is up 10.91% while the S&P 500 is lower by -2.56% as of 12:44 PM on Thursday, Dec 15. SIOX is up $0.04 from the previous closing price of $0.36 on volume of 4,623,680 shares. Over the past year the S&P 500 has fallen -16.00% while SIOX is lower by -69.47%. SIOX lost -$0.68 per share in the over the last 12 months.

More About Sio Gene Therapies Inc

Sio Gene Therapies Inc is a clinical-stage company that is focused on gene therapy for neurodegenerative diseases. The company is developing its pipeline for the treatment of debilitating diseases, including Parkinson's disease, GM1 gangliosidosis, and GM2 gangliosidosis. Click Here to get the full Stock Report for Sio Gene Therapies Inc stock.